Brief: IRLAB Therapeutics Q3 Operating Loss Widens To SEK 26.9 Mln

IRLAB Therapeutics AB

11/11/2020 06:46

Nov 11 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * Q3 OPERATING LOSS SEK 26.9 MILLION VERSUS LOSS SEK 21.5
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkr4lcJ0N 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))